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SUMMARY 
Adenylate cyclase activities have been assayed in the human fetal adrenal, 
heart ventricle, brain, liver, testis, kidney, skeletal muscle and lung during the first 
trimester of pregnancy. The requirements for adenylate cyclases are similar to those 
reported in all adult tissues. Of all tissues studied, heart ventricle had the highest 
level of enzymatic activity, and this tissue was most responsive to hormonal stimu- 
lation. Although adenylate cyclases from all of these tissues were stimulated by F -  
in vitro, hormonal stimulation was observed only in the liver, adrenal and heart ven- 
tricle. The presence of hormone-responsive adenylate cyclase in human fetal tissues 
suggests that cyclic AMP may be involved in gene expression. 
INTRODUCTION 
Development of an organism from fertilization to maturity is characterized 
by an orderly progression of enzyme protein formation, which eventually leads to 
acquisition of the complete metabolic machinery characteristic of differentiated tissue. 
In fetal rat liver, the enzymes responsible for glucose oxidation and amino acid meta- 
bolism (e.g. tryptophan oxygenase, tyrosine aminotransferase, and glucose-6-phos- 
phatase) are absent but rise postnataily to adult levels 1 - 4. It has been shown that the 
formation of tyrosine aminotransferase and glucose-6-phosphatase can be induced 
prematurely by the administration of glucagon to fetal rats. Injection of dibutyryl 
cyclic AMP directly into fetal rats also causes premature formation of the above 
enzymes 5. From these experiments, it was inferred that cyclic AMP is a mediator of 
glucagon action in the fetal rat liver, which in turn causes premature appearance of 
amino acid metabolizing enzymes. 
Since cyclic AMP has been shown to play a role in the differentiation of hepatic 
enzymes in the fetus, it was of interest to investigate the presence of hormone-sensitive 
adenylate cyclases in developing human fetal tissues. The present investigation of 
Abbreviations: HCG, human chorionic gonadotropin; ACTH, adrenocorticotropic hor- 
mone; LH, luteinizing hormone. 
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adenylate cyclases was undertaken to determine (a) if human fetal tissues at early 
stages of differentiation possess these enzymes, (b) in vitro requirements for their 
activity and (c) their responsiveness to appropriate hormones and to F - .  
MATERIALS AND METHODS 
Human tissues 
Three human fetuses of 12, 13, and 12 weeks estimated gestational age were 
obtained at the time of hysterotomy performed for psychosocial reasons. The tissues 
were removed and immediately frozen in an alcohol-solid CO z mixture and sub- 
sequently stored at - 8 0  °C until assayed. 
Chemicals 
[U-14C]ATP was purchased from New England Nuclear Corp. Pyruvate 
kinase and cyclic AMP were purchased from Sigma Chemical Co. and phosphoenol 
pyruvate was obtained from Cal Biochem. Luteinizing hormone (LH) (N.I.H.-LH- 
B7) was generously donated by the Endocrine Study Section, National Institutes of 
Health. Human chorionic gonadotropin (HGG)  (Antuitrin "S"),  adrenocorticotropic 
hormone (ACTH) and epinephrine were purchased from commercial sources. All 
other chemicals were conventional commercial products. 
Preparation of enzyme 
Fetal tissues were homogenized in 5 vol. of 0.01 M Tris-HCl, pH 7.5 for 1 min 
at 0 °C in a glass homogenizer with a teflon pestle using a TRI-R motor. The homo- 
genates were strained through four layers of cheesecloth. These preparations were 
assayed within 10 min. 
Assay of adenylate cyclase 
The enzyme assays were performed by the procedure described by Drummond 
and Duncan 6. The assay mixture contained the following substances in a final volume 
of  150#1:1 ktCi of [U-~4C]ATP (16 Ci/mole), 14 mM MgC12, 35 mM Tris-HCl, 
pH 7.5, 8.0 mM theophylline, 7 mM KC1, 7 mM KF, 18 mM phosphoenolpyruvate, 
3.0 units of pyruvate kinase and 2 mM cyclic AMP. In those experiments in which 
hormonal responses were tested, the incubation mixture did not contain F - .  After 
the incubation (usually 15 rain), the tubes were heated in a boiling water bath for 
3 min and then centrifuged for 5 min at 4000 rev./min in a Sorvall centrifuge. The 
supernatant solution (100/tl) was then applied to Whatman No. 40 filter paper and 
chromatographed in 1 M ammonium acetate (pH 7.5)-ethanol (3 : 7, by vol.) for 
16 h at room temperature. Authentic samples of ATP, ADP, AMP, cyclic AMP, 
adenosine and inosine were chromatographed parallel to the incubation mixture. 
After drying the chromatograms, the areas corresponding to cyclic AMP were marked 
on the chromatograms, cut out and placed in scintillation vials. The radioactivity 
on the chromatograms was determined by liquid scintillation spectrometry after the 
addition of 15 ml of  scintillation fluid (4 g of PPO and 50 mg POPOP in 1 1 toluene). 
Characterization of cyclic [14C]AM P 
For characterization purposes, the areas on chromatograms corresponding to 
cyclic AMP were eluted with water 7 and then lyophilized. The residues were then 
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dissolved in water  and incubated with cyclic nucleot ide phosphodies terase  as described 
by Butcher  and Suther land s. The  incubat ion  mixtures  were then ch roma tog raphed  
in the same system as described for the adenylate  cyclase and the areas cor responding  
to A M P  were then eluted and the radioact ivi ty  determined.  
RESULTS 
Requirements  f o r  the enzyme 
Like the adenylate  cyclases f rom other  sources 6,9-12, those derived f rom fetal 
tissues required Mg  2 ÷ for  activity (Table I). M n  2 ÷ also had a similar effect. The Mg  2 ÷ 
concent ra t ion  curve for  adenylate cyclase in fetal heart  is shown in Fig. 1A. The 
adenylate  cyclases f rom h u m a n  fetal tissues were also s t imulated by F - .  The concen-  
t ra t ion curve for  F -  s t imulat ion in human  fetal hear t  is shown in Fig. 1B. 
TABLE I 
REQUIREMENTS FOR Mg 2+ FOR IN VITRO ADENYLATE CYCLASE ACTIVITY IN 
HUMAN FETAL TISSUES 
Experimental conditions are described in text. Data presented are from tissues of one fetus. The 
data from the other two fetuses were similar. 
Tissue MO 2 + addition* Enzymic activity** 
Heart ventricle -- 6 
-? 800 
Liver -- 3 
+ 100 
Adrenal -- 4 
+ 138 
Brain - -  6 
+ 209 
Testis -- 4 
+ 156 
Skeletal muscle -- 4 
+ 93 
Lung -- 6 
+ 132 
Kidney -- 4 
+ 132 
* All incubations were performed in the presence of F-.  When M g  2+ w a s  present, the concen- 
tration was 17 raM. 
** Enzymic activity expressed as pmoles of cyclic AMP formed per rain per mg protein. The 
identity of cyclic AMP was established by the procedure described in the text. 
Effect  o f  hormones 
Since adenylate cyclases f rom adult  m a m m a l i a n  tissues are responsive to a 
wide variety o f  protein,  polypept ide  and neurohormones ,  the influences o f  some ot 
these s t imulants  were tested in appropr ia te  human  fetal tissues. Since the a m o u n t  ot 
avai lable tissue f rom each fetus was too  small to permit  replicate determinat ions  
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Fig. 1. (A)  Effect of  Mg 2+ concentration on adenylate cyclase activity in human fetal heart ven- 
tricle at 12 weeks o f  gestation. (B) Effect of  F -  on adenylate cyclase activity in human fetal heart 
ventricle at 12 weeks gestation. 
statistical analysis was precluded. The findings from three individual fetuses are de- 
scribed. 
Human fetal heart adenylate cyclase was responsive /n vitro to both epineph- 
rine and glucagon in all three fetuses studied as shown in Fig. 2. The extent of 
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Fig. 2. Effects o f  F - ,  epinephrine and glucagon on adenylate cyclase activities in heart ventricles 
of  three human fetuses. 
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Fig. 3. Effects o f  F - ,  epinephrine and glucagon on adenylate cyclase activities in liver from three 
human fetuses. 
stimulation by epinephrine was a function of the added hormone. Maximal stimulation 
of adenylate cyclase was observed at 10-4 M. The extent of stimulation caused by 
F-  was far greater than that caused by maximal concentrations of hormones. 
Fetal liver adenylate cyclases from the three fetuses were responsive to glucagon 
and epinephrine as shown in Fig. 3. Again, the effect of F -  was greater than that 




~ 80  
~ 7o 









~ ,o i'li  
FETUS 
r~ Conlrol 
[ ]  Fluoride 
ACTH 
I L H  
~I HCG 
I~ Aibumln 
FETUS 2 FETUS 3 
Fig. 4. Effects o f  A C T H  and other substances on the adenylate cyclase activities in adrenals from 
three human fetuses. 
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was concentration dependent and specific as LH, HCG and albumin were without 
any effect (Fig. 4). 
The adenylate cyclases from testis, lungs, skeletal muscle, kidney and brain 
were not stimulated by the in v i t ro  addition of hormone. The hormones tested were 
LH and HCG in the testis, epinephrine in lungs, vasopressin in kidney, catecholamines 
and glucagon in skeletal muscle, and neurohormones in the brain. The areas of brain 
studied were cerebrum, cerebellum and medulla oblongata. There were no significant 
differences in the adenylate cyclase activities in these different areas of brain. All 
these tissues were responsive to F- .  
DISCUSSION 
This study has been aimed at understanding developmental aspects of adenylate 
cyclase in human fetal tissues. Attention was focused on the earliest periods in human 
fetal growth at which tissues were morphologically differentiated and sufficient 
amounts of tissue for performance of the assays could be identified and obtained. 
One interesting aspect of the study is the close similarity in the requirements 
for adenylate cyclase with respect to the concentrations of F -  and Mg 2 + in the human 
fetus and tissues from other species. The data presented here are in agreement with 
the findings of Drummond and Duncan 6 for guinea pig ventricle and Menon and 
Smith a2 for salmon testis. 
Of  all the fetal tissues studied, the heart ventricle had the highest levels of ade- 
nylate cyclase activity. Additionally, the heart ventricle was the most responsive tissue 
to catecholamine stimulation. Fetal liver was responsive to both glucagon and epine- 
phrine. The adenylate cyclases from fetal adrenal were stimulated by ACTH and this 
effect appeared specific, as HCG, LH and albumin were without any effect. By this 
stage of gestation, the human fetal adrenal plays a key role in feto-placental steroido- 
genesis. The observation that ACTH stimulated adenylate cyclase suggests establish- 
ment of the pituitary-adrenal axis by this stage of development. The adenylate cyclase 
from skeletal muscle was only slightly responsive to catecholamines (8 ~) .  This is in 
contrast to the adult in which several hormones are reported to stimulate cyclic AMP 
production in this tissue. Catecholamines did not stimulate adenylate cyclase in the 
various areas of fetal brain studied. It has been reported that a homogenate from 
brain tissue was not stimulated by catecholamines 13, but a slice preparation readily 
responded to these hormones 14-16. We have not studied possible hormonal influence 
in a slice preparation of brain. Adenylate cyclase from fetal testis did not respond 
to LH. As testosterone can be synthesized d e  n o v o  in the human fetal testis by this 
gestational age iv, and as testicular androgen is important in sexual differentiation, 
failure to observe activation of adenylate cyclase in the testes is of interest. Whether 
this is because the fetal testis is functioning autonomously at this stage of gestation, 
or whether it is due to an artifact of the incubation system used, awaits further 
elucidation. Furthermore, oxytocin did not stimulate adenylate cyclase in the fetal 
kidney and epinephrine was ineffective in lungs. These findings stand in contrast to 
those in adult tissues of  other species. 
Adenylate cyclases from all the fetal tissues responded to F -  and in those 
experiments in which hormones did activate adenylate cyclases, the extent of stimu- 
lation caused by F -  was always greater than the hormonal responses. Schmidt and 
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R o b i s o n  ~8 repor ted  tha t  the adenyla te  cyclase f rom rat  bra in  was s t imula ted  by F -  
on ly  10 days  after  b i r th  but  not  in the fetus, nor  in ear l ier  pos tna ta l  life. This s i tua t ion  
is in con t ras t  to the F -  responsiveness  o f  adenyla te  cyclase observed in the h u m a n  
fetal brain.  
The  presence o f  adenyla te  cyclase in h u m a n  fetal tissues, especial ly their  
ac t ivat ion by  hormones ,  may  have i m p o r t a n t  b io logica l  ramificat ions.  The presence 
o f  adenyla te  cyclase suggests tha t  cyclic A M P  may  cont ro l  deve lopmenta l  processes 
such as gene express ion s. The h o r m o n a l  responsiveness  in the heart ,  adrenal  and  liver 
can be in terpre ted  as an  ind ica t ion  that  the h o r m o n e  recogni t ion  site (d i sc r imina tor )  
may  be present  in these tissues f rom early stages in fetal development .  
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